Lack of evidence for ribavirin-induced bone loss [2]

Hepatology

Volumn 36, Issue 1, 2002, Pages 255-257

  Trombetti, Andrea ^a   Giostra, Emiliano ^a   Mentha, Gilles ^a   Negro, Francesco ^a   Rizzoli, Rene ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CALCIUM; CREATININE; RIBAVIRIN; VITAMIN D;

ADULT; BONE ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036288280     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.33711     Document Type: Letter

References (6)

1. Hepatitis C virus infection
2. Immunological and antiviral effects of ribavirin in hepatitis C after liver transplant: A pilot study
3. Perspective: The diagnosis of osteoporosis
4. Bone mineral density of the lumbar spine, the femoral neck, and femoral diaphysis in a Genevan population sample
5. Decreased bone mineral density after therapy with interferon in combination with ribavirin for chronic hepatitis C